Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.43 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 5/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | PPARA | Q07869 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9621312 | 0.79 | HRH3 (0.45) | HRH3DAOHTR1ADRD2HTR2A | |
| SCHEMBL6513576 | 0.77 | ALDH1A1 (0.49) | DRD2CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL6841220 | 0.76 | HRH3 (0.43) | HRH3DAOHTR1ADRD2HTR2A | |
| SCHEMBL5539635 | 0.76 | ALDH1A1 (0.56) | DRD2DRD3CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL2095616 | 0.75 | TAAR1 (0.50) | DAOPPARDIDO1PPARAKMT2A | |
| SCHEMBL29391559 | 0.74 | DAO (0.44) | HRH3DAOHTR1ADRD2HTR2A | |
| SCHEMBL2096840 | 0.72 | TAAR1 (0.47) | DAOIDO1KMT2AMAOB | |
| SCHEMBL23867049 | 0.72 | HRH3 (0.49) | HRH3DAOHTR1ADRD2HTR2A | |
| SCHEMBL13799440 | 0.72 | AR (0.50) | HRH3DAOHTR1ADRD2HTR2A | |
| SCHEMBL4904511 | 0.72 | TAAR1 (0.50) | HRH3DAOHTR1ADRD2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6759511-B2 | A CARBONIC ACID 4-NITRO-PHENYL ESTER 2-(4-TRIFLULOROMETHYL-PHENYLSULFANYL)-ETHYL ESTER AS CHEMICAL INTERMEDIATES; AMIDATION, CARBOXYLATION, SULFONATION | HANCHEM CO., LTD. (KR) | 2004-07-06 | — | — | US | disclosed |
| US-20030220469-A1 | Novel compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same | HANCHEM CO., LTD. (KR) | 2003-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220469-A1 | Novel compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same | NGLY1, VIP, BCAT2 | HRH3 3532/4885DAO 21/4885HTR1A 3760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.